Oral formulations of cytidine analogs and methods of use thereof
US12053482B2 · kind B2 · utility
0Cited by
32References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 24, 2023 |
| Grant date | Aug 6, 2024 |
| Priority date | — |
| Expiry date | Apr 24, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.